Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc., listed under the ticker PWUP, is a biopharmaceutical-sector SPAC that submitted an 8-K filing with the Securities and Exchange Commission on August 30, 2024, bearing accession number 0001493152-24-034646. The vehicle targets the life sciences and biopharma industry and reflects the continued corporate activity common among SPACs navigating post-combination or late-stage transaction milestones. The August 2024 disclosure represents a material event in the company's development trajectory within a sector that has drawn sustained SPAC sponsor interest over recent deal cycles. To access complete sponsor details, deal timelines, SEC filing histories, and comparable SPAC metrics for PWUP and the broader SPAC universe, sign up for full data on SpacDesk.